Search results
Results from the WOW.Com Content Network
Various nonnutritive sweeteners have also been linked to heart disease and early death, migraines, depression, dementia, disruptions in gut microbiomes, cancer and cognitive, behavioral and ...
Sucralose is used in many food and beverage products because it is a non-nutritive sweetener (14 kilojoules [3.3 kcal] per typical one-gram serving), [3] does not promote dental cavities, [7] is safe for consumption by diabetics and nondiabetics [8] and does not affect insulin levels. [9]
One of the world's most common artificial sweeteners is set to be declared a possible carcinogen next month by a leading global health body, according to two sources with knowledge of the process ...
A sugar substitute is a food additive that provides a sweetness like that of sugar while containing significantly less food energy than sugar-based sweeteners, making it a zero-calorie (non-nutritive) [2] or low-calorie sweetener. Artificial sweeteners may be derived through manufacturing of plant extracts or processed by chemical synthesis ...
High consumption of artificially sweetened beverages is associated with an increased risk of all-cause mortality and cardiovascular disease (CVD) mortality. [10] [11] [12] The National Cancer Institute, Cancer Council Australia and Cancer Research UK have stated there is no convincing evidence that artificial sweeteners cause cancer. [52] [53] [54]
The sweeteners were originally billed as a healthier replacement for sugar, which is known to promote obesity and diabetes and can increase one's risk of heart disease if consumed in excess.
The risk of developing type 2 diabetes, stroke, and depression may be higher in people with a "sweet tooth" who prefer sugary foods, new research suggests.
The artificial sweetener aspartame has been the subject of several controversies since its initial approval by the U.S. Food and Drug Administration (FDA) in 1974. The FDA approval of aspartame was highly contested, beginning with suspicions of its involvement in brain cancer, [1] alleging that the quality of the initial research supporting its safety was inadequate and flawed, and that ...